News Detail

Sero-surveillance: Random Community Testing to Assess Prevalence of COVID-19 Infection in Mumbai


In a joint venture between Tata Institute of Fundamental Research (TIFR), Translational Health Science and Technology Institute (THSTI, Faridabad), University of Chicago, Duke University, ATE Chandra Foundation (Mumbai), Kasturba Hospital (Mumbai) and IDFC Institute (Mumbai), under the aegis of the NITI Aayog, a pilot project was launched on 29 June 2020 to understand the extent to which the population in Mumbai has already been exposed to COVID-19 infection and predict the future spread of the infection. In the initial stage of this project, 10,000 blood samples will be randomly collected from asymptomatic Mumbai residents in the age group above 12 years (both in the slum and non-slum areas).


Sero-surveillance: Random Community Testing to Assess Prevalence of COVID-19 Infection in Mumbai